Novel MitoXcel-Powered Geropeptide Platform Our MitoXcel Geropeptide Lead Clinical Candidates PTC-2105 and PTC-2107, Are: 18- to 30-amino acids in length Cross the blood brain barrier Administered via SC injection over an 8-16 week, and longer, course of treatment in pre-clinical models Key Findings: Selective Elimination of Senescent Cells: In all organs of the body, including the brain, in a dose dependent manner Reduced Systemic Inflammation: Significant decrease in SASP biomarkers Tissue Remodelling to a Healthier Phenotype in Muscle and Fat: Improved body composition including a reduction in fat but an increase in lean body and bone mass Improved Physical Health: Enhanced metabolism, muscle strength, and exercise endurance
The hormonal causes of cravings Our bodies produce numerous peptides (molecules with 2 or more amino acids) that naturally suppress hunger when weve eaten enough
Analytic Approach National all-payer claims data were used to examine patient volumes for bariatric weight loss surgery, cardiac catheterization, GLP-1 medication use and SGLT2 inhibitor medication use from 2018 to 2023
Efficacy and Safety of GLP-1 Agonists on Metabolic Parameters in Non-diabetic Patients with Inflammatory Bowel Disease
These shots can start to work right away